Literature DB >> 25524706

Structural basis for misfolding in myocilin-associated glaucoma.

Rebecca K Donegan1, Shannon E Hill1, Dana M Freeman1, Elaine Nguyen1, Susan D Orwig1, Katherine C Turnage1, Raquel L Lieberman2.   

Abstract

Olfactomedin (OLF) domain-containing proteins play roles in fundamental cellular processes and have been implicated in disorders ranging from glaucoma, cancers and inflammatory bowel disorder, to attention deficit disorder and childhood obesity. We solved crystal structures of the OLF domain of myocilin (myoc-OLF), the best studied such domain to date. Mutations in myoc-OLF are causative in the autosomal dominant inherited form of the prevalent ocular disorder glaucoma. The structures reveal a new addition to the small family of five-bladed β-propellers. Propellers are most well known for their ability to act as hubs for protein-protein interactions, a function that seems most likely for myoc-OLF, but they can also act as enzymes. A calcium ion, sodium ion and glycerol molecule were identified within a central hydrophilic cavity that is accessible via movements of surface loop residues. By mapping familial glaucoma-associated lesions onto the myoc-OLF structure, three regions sensitive to aggregation have been identified, with direct applicability to differentiating between neutral and disease-causing non-synonymous mutations documented in the human population worldwide. Evolutionary analysis mapped onto the myoc-OLF structure reveals conserved and divergent regions for possible overlapping and distinctive functional protein-protein or protein-ligand interactions across the broader OLF domain family. While deciphering the specific normal biological functions, ligands and binding partners for OLF domains will likely continue to be a challenging long-term experimental pursuit, atomic detail structural knowledge of myoc-OLF is a valuable guide for understanding the implications of glaucoma-associated mutations and will help focus future studies of this biomedically important domain family.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25524706      PMCID: PMC4380063          DOI: 10.1093/hmg/ddu730

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  104 in total

Review 1.  Novel sequences propel familiar folds.

Authors:  Zahra Jawad; Massimo Paoli
Journal:  Structure       Date:  2002-04       Impact factor: 5.006

Review 2.  The many blades of the β-propeller proteins: conserved but versatile.

Authors:  Cammy K-M Chen; Nei-Li Chan; Andrew H-J Wang
Journal:  Trends Biochem Sci       Date:  2011-09-15       Impact factor: 13.807

3.  Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two beta-propeller domains.

Authors:  M Paoli; B F Anderson; H M Baker; W T Morgan; A Smith; E N Baker
Journal:  Nat Struct Biol       Date:  1999-10

4.  Rescue of glaucoma-causing mutant myocilin thermal stability by chemical chaperones.

Authors:  J Nicole Burns; Susan D Orwig; Julia L Harris; J Derrick Watkins; Douglas Vollrath; Raquel L Lieberman
Journal:  ACS Chem Biol       Date:  2010-05-21       Impact factor: 5.100

5.  A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication.

Authors:  M Arcos-Burgos; M Jain; M T Acosta; S Shively; H Stanescu; D Wallis; S Domené; J I Vélez; J D Karkera; J Balog; K Berg; R Kleta; W A Gahl; E Roessler; R Long; J Lie; D Pineda; A C Londoño; J D Palacio; A Arbelaez; F Lopera; J Elia; H Hakonarson; S Johansson; P M Knappskog; J Haavik; M Ribases; B Cormand; M Bayes; M Casas; J A Ramos-Quiroga; A Hervas; B S Maher; S V Faraone; C Seitz; C M Freitag; H Palmason; J Meyer; M Romanos; S Walitza; U Hemminger; A Warnke; J Romanos; T Renner; C Jacob; K-P Lesch; J Swanson; A Vortmeyer; J E Bailey-Wilson; F X Castellanos; M Muenke
Journal:  Mol Psychiatry       Date:  2010-02-16       Impact factor: 15.992

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Founder TIGR/myocilin mutations for glaucoma in the Québec population.

Authors:  Mathieu Faucher; Jean-Louis Anctil; Marc-André Rodrigue; Annie Duchesne; Dan Bergeron; Pierre Blondeau; Gilles Côté; Stéphane Dubois; Josée Bergeron; Rose Arseneault; Jean Morissette; Vincent Raymond
Journal:  Hum Mol Genet       Date:  2002-09-01       Impact factor: 6.150

8.  Myocilin modulates programmed cell death during retinal development.

Authors:  Marcus A Koch; Bernd Rosenhammer; Sebastian E Koschade; Barbara M Braunger; Cornelia Volz; Herbert Jägle; Ernst R Tamm
Journal:  Exp Eye Res       Date:  2014-05-15       Impact factor: 3.467

Review 9.  Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology.

Authors:  Stanislav I Tomarev; Naoki Nakaya
Journal:  Mol Neurobiol       Date:  2009-06-26       Impact factor: 5.590

10.  Pro370Leu mutant myocilin disturbs the endoplasm reticulum stress response and mitochondrial membrane potential in human trabecular meshwork cells.

Authors:  Lina Wang; Yehong Zhuo; Bingqian Liu; Shengsong Huang; Fei Hou; Jian Ge
Journal:  Mol Vis       Date:  2007-04-19       Impact factor: 2.367

View more
  43 in total

Review 1.  Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.

Authors:  Rebecca K Donegan; Raquel L Lieberman
Journal:  J Med Chem       Date:  2015-09-25       Impact factor: 7.446

2.  Differential Misfolding Properties of Glaucoma-Associated Olfactomedin Domains from Humans and Mice.

Authors:  Athéna C Patterson-Orazem; Shannon E Hill; Yiming Wang; Iramofu M Dominic; Carol K Hall; Raquel L Lieberman
Journal:  Biochemistry       Date:  2019-03-12       Impact factor: 3.162

3.  Trifunctional High-Throughput Screen Identifies Promising Scaffold To Inhibit Grp94 and Treat Myocilin-Associated Glaucoma.

Authors:  Dustin J E Huard; Vincent M Crowley; Yuhong Du; Ricardo A Cordova; Zheying Sun; Moya O Tomlin; Chad A Dickey; John Koren; Laura Blair; Haian Fu; Brian S J Blagg; Raquel L Lieberman
Journal:  ACS Chem Biol       Date:  2018-02-20       Impact factor: 5.100

4.  Pocket detection and interaction-weighted ligand-similarity search yields novel high-affinity binders for Myocilin-OLF, a protein implicated in glaucoma.

Authors:  Bharath Srinivasan; Sam Tonddast-Navaei; Jeffrey Skolnick
Journal:  Bioorg Med Chem Lett       Date:  2017-07-12       Impact factor: 2.823

5.  Stable calcium-free myocilin olfactomedin domain variants reveal challenges in differentiating between benign and glaucoma-causing mutations.

Authors:  Shannon E Hill; Michelle S Kwon; Mackenzie D Martin; Amirthaa Suntharalingam; Anthony Hazel; Chad A Dickey; James C Gumbart; Raquel L Lieberman
Journal:  J Biol Chem       Date:  2019-07-02       Impact factor: 5.157

Review 6.  The impact of structural biology in medicine illustrated with four case studies.

Authors:  Tiancen Hu; Elizabeth R Sprague; Michelle Fodor; Travis Stams; Kirk L Clark; Sandra W Cowan-Jacob
Journal:  J Mol Med (Berl)       Date:  2017-07-01       Impact factor: 4.599

Review 7.  Genetics of glaucoma.

Authors:  Janey L Wiggs; Louis R Pasquale
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

Review 8.  Major review: Molecular genetics of primary open-angle glaucoma.

Authors:  Yutao Liu; R Rand Allingham
Journal:  Exp Eye Res       Date:  2017-05-10       Impact factor: 3.467

9.  Simulations and Experiments Delineate Amyloid Fibrilization by Peptides Derived from Glaucoma-Associated Myocilin.

Authors:  Yiming Wang; Yuan Gao; Shannon E Hill; Dustin J E Huard; Moya O Tomlin; Raquel L Lieberman; Anant K Paravastu; Carol K Hall
Journal:  J Phys Chem B       Date:  2018-05-21       Impact factor: 2.991

10.  Epitope mapping of commercial antibodies that detect myocilin.

Authors:  Athéna C Patterson-Orazem; Shannon E Hill; Michael P Fautsch; Raquel L Lieberman
Journal:  Exp Eye Res       Date:  2018-05-09       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.